@windowpound31
Active 8 months, 3 weeks ago
e associated with a low bleeding risk. Our data support consideration of a 2-4 week trial of antithrombotic therapy, usually starting with antiplatelet therapy, in aPL-positive patients with refractory migraine, particularly if other treatment options have been exhausted. As a retrospective study, our data provide only Class IV level of e […] View
Sorry, there was no activity found. Please try a different filter.